Published in AIDS Weekly, September 21st, 2009
"Of them, 255 (18.5%) had CD4 increases >= 100 cells/mu l after 1 year of therapy despite detectable viral load (immunological responders); they were compared with 669 patients (48.5%) who had CD4 increases <100 cells/mu l regardless of their final viral load (immunological nonresponders). Immunological responders...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.